# A Study of Ingested Cannabidiol in Healthy Occasional Cannabis Users

> **NCT05407285** · PHASE1,PHASE2 · COMPLETED · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 70 (actual)

## Conditions studied

- Cannabis

## Interventions

- **DRUG:** cannabis 0 mg, placebo
- **DRUG:** Cannabis 20 mg,
- **DRUG:** Cannabis 50 mg
- **DRUG:** Cannabis 100 mg
- **DRUG:** Cannabis 200 mg

## Key facts

- **NCT ID:** NCT05407285
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-22
- **Primary completion:** 2023-11-14
- **Final completion:** 2023-11-14
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2024-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05407285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05407285, "A Study of Ingested Cannabidiol in Healthy Occasional Cannabis Users". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05407285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*